GORMAN KEVIN CHARLES bought NBIX

January 27, 2025 · Form 4 insider transaction

GORMAN KEVIN CHARLES bought 146,105 shares of Neurocrine Biosciences, Inc. at $32.99 per share, a transaction worth $4.82M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.